Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE).

NACompletedINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

April 20, 2018

Primary Completion Date

June 18, 2020

Study Completion Date

June 18, 2020

Conditions
Solid Tumor
Interventions
OTHER

Patients starting a treatment by ICI

"Completion of the Quality of Life Questionnaire Core 30 (QLQ-C30) before treatment administration and during the 12 months of treatment period, at the following time points:~* every 6 weeks for treatment regimen administered every 2 or 3 weeks~* at Weeks 6, 12, 20, 24 for treatment regimen administered every 4 weeks"

Trial Locations (6)

31059

Hopital Larrey, Toulouse

Institut Universitaire Du Cancer de Toulouse - Oncopole, Toulouse

34298

Institut Regional Du Cancer de Montpellier (Icm), Montpellier

75005

Institut Curie, Paris

Unknown

CH ALBI, Albi

Ch Castres, Castres

All Listed Sponsors
lead

Institut Claudius Regaud

OTHER

NCT03447483 - Cohort Study: Modelling Toxicity Processing in Patients Treated by Immunotherapy (MOTIVATE). | Biotech Hunter | Biotech Hunter